Unconventional multidisciplinary team strategy for tracheostomy in COVID‐19

1Consultant, Department of Anaesthesia, 4 Fellow, 5Consultant, Department ofOtorhinolaryngology, Guy’s and St Thomas’NHS Foundation Trust, London, UK 2Clinical Senior Lecturer, Centre for Human andApplied Physiological Sciences, 3 Honorary Senior Lecturer, King’s College London, London, UK ............................................................................................................................................................................................................................................................................................................ Correspondence to: T. G. Smith Email: thomas.g.smith@kcl.ac.uk Accepted: 3 September 2020

Twitter: @dr_imranahmad; @elboghdadly The approach an institution takes to tracheostomy during the coronavirus disease 2019 (COVID-19) pandemic has broad potential to influence morbidity and mortality, as tracheostomy is at the intersection of patient-centred care, healthcare worker safety and resource allocation [1]. Consensus guidance is, by necessity, based largely on expert opinion, and real-world experience is required [1]. We have accumulated extensive experience using an unconventional multidisciplinary team strategy in which percutaneous dilatational tracheostomy is undertaken at the bed-side in open intensive care units (ICUs) by teams combining anaesthetists and surgeons. In the context of a strained critical care system, greater resource efficiency is a crucial benefit of this approach.
Our institution has been at the epicentre of the UK pandemic, admitting hundreds of patients to regular and 'surge' ICUs.
There has been a very high requirement for tracheal intubation and mechanical ventilation, and subsequently for tracheostomy.
We established mobile emergency rapid intubation teams (MERIT) early in the pandemic response, which follow specific protocols for personal protective equipment (PPE) and minimising aerosol generation and thus operator risk of infection [2].
Mobile emergency rapid intubation teams, consisting of two consultant anaesthetists and two assistants, are responsible for all COVID-19 tracheal intubations in the hospital [3]. Our key multidisciplinary innovation was to then develop a dedicated tracheostomy team comprising two ear, nose and throat (ENT) surgeons and two MERIT anaesthetists. To our knowledge, we were the first UK centre to develop such teams and publish guidelines for tracheostomy in COVID-19 including procedures for PPE, minimising aerosolisation and improved success with minimal complications [4].
ENT surgeons have been involved in 'surge' tracheostomy strategies in other centres, for example, instituting a dedicated tracheostomy theatre. However, our approach was distinct and unusual both in combining ENT surgeons with anaesthetists to form a tracheostomy team and, crucially, in this team undertaking percutaneous tracheostomies independently at the bed-side in the ICU. This was in contrast to normal practice where tracheostomies would be inserted either by ICU operators alone, or alternatively in the operating theatre as a surgical tracheostomy.
The ENT/MERIT tracheostomy team has quickly developed expertise in using advanced PPE and minimising aerosolisation in accordance with carefully devised procedures including a step-by-step protocol for bed-side tracheostomy (Fig. 1). This protocol includes the use of ultrasound to identify structures and mark a 'never above' line to minimise the risk of damaging the tracheal tube cuff, as well as videolaryngoscopy to view the tracheal tube cuff and fibreoptic bronchoscopy for internal viewing.
Our self-contained team model promotes efficient use of personnel and resources by relieving ICU staff and avoiding ICUtheatre transfers. At our institution, it has also exploited changing capacity of MERIT anaesthetists as the requirement for tracheostomies has progressively overtaken primary intubations. Outcomes from our first 28 tracheostomies have been  Table 1).
The presence of ENT surgeons in the team may have allowed more challenging tracheostomies that would not normally be attempted in ICU (e.g. obese patients) to still be undertaken in the most resource-efficient manner. While the ideal location for performing a tracheostomy on a COVID-19-positive patient is in a negative pressure side room or operating theatre, this may not be available, and transferring critically ill patients to theatre also has major resource and safety implications. Recent preliminary data from a national UK audit (UK COVIDTrach) indicate that percutaneous tracheostomy is at least as safe as surgical tracheostomy in COVID-19 [5]. Anecdotally, percutaneous tracheostomies may be less prone to wound site infections and dislodgement in the presence of thick tenacious secretions in COVID-19.
Until further data are forthcoming, we recommend consideration of this multidisciplinary team model and protocol for tracheostomy in COVID-19 in order to deliver safe patient-centred care and support healthcare worker safety while simultaneously optimising the balance between these priorities and the efficient utilisation of scarce resources.  Significant complications from tracheostomy* 0 (0%) Transmission of COVID-19 to operators 0 (0%) Mortality 0 (0%) *Significant complications are defined as Clavien-Dindo Grade 2 or higher. APACHE II, acute physiology and chronic health evaluation II score; FiO 2 , fraction of inspired oxygen; PaO 2 , arterial partial pressure of oxygen; PEEP, positive end-expiratory pressure; P/F ratio, PaO 2 /FiO 2 ratio. 182